IGF1 and obstructive sleep apnea syndrome: Renewed interest in the IGF-1 pathway has nevertheless been generated by the observation that the second receptor for IGF-1 (IGF-2R) is also expressed in both human and canine OSA tissues, indicating that it may have potential as a comparative therapeutic target [145,146].